Central nervous system (CNS) viral infections result in the clinical syndromes of aseptic meningitis or encephalitis. Although the primary target of coronavirus disease 2019 (COVID-19) is the respiratory system, it is increasingly being recognized as a neuropathogen. The hallmark clinical feature is altered mental status, ranging from mild confusion to deep coma. Most patients with encephalopathy or encephalitis are critically ill. We present a case of COVID-19-related encephalitis who presented with acute delirium and new-onset seizures. The patient responded well to treatment with intravenous immunoglobulins and rituximab.
All Keywords
【저자키워드】 Coronavirus disease 2019, rituximab, viral encephalitis, acute encephalopathy, 【초록키워드】 Treatment, viral infection, Intravenous immunoglobulin, Encephalitis, Patient, nervous system, Meningitis, Mild, Encephalopathy, Respiratory system, disease, CNS, Altered mental status, Confusion, Acute delirium, syndrome, Coma, hallmark, Most patient, increasingly, 【제목키워드】 COVID-19, clinical, manifestation,
【저자키워드】 Coronavirus disease 2019, rituximab, viral encephalitis, acute encephalopathy, 【초록키워드】 Treatment, viral infection, Intravenous immunoglobulin, Encephalitis, Patient, nervous system, Meningitis, Mild, Encephalopathy, Respiratory system, disease, CNS, Altered mental status, Confusion, Acute delirium, syndrome, Coma, hallmark, Most patient, increasingly, 【제목키워드】 COVID-19, clinical, manifestation,